Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This facility will be cGMP capable for Drug Product supplies, and will expand our ability to offer integrated Drug Substance (DS) and Drug Product (DP) R&D Services and early clinical supplies to our client base. The facility will operate under the leadership of Dr. Jian Wang, Sr. Vice President of Crystallization R&D and Drug Product within J-Star Research.

Occupying over 40,000 square feet of space, this $20M new addition will offer our employees and our customers state of the art capabilities; including six cGMP suites for Drug Product, expanded Crystallization R&D and Reaction Engineering laboratories, offices and supporting utilities. It will host about 70 DS and DP scientists, specializing in various areas such as salt selection, polymorph screening, crystallization process development, particle size engineering, pre-formulation development, preparation of Phase 1/2 Drug product supplies and DS-DP co-processing.

The facility will be located on 2 Clarke Drive, a few minutes walking distance from our current facility at 6 Cedarbrook Drive in Cranbury. This will allow our scientists to seamlessly collaborate on projects, and bring projects to completion faster. Our teams are excited to begin populating the building with equipment, personnel, and projects as soon as construction is complete.